CONCENTRIS RESEARCH MANAGEMENT GMBH

logo

  Ludwigstr. 4 – Furstenfeldbruck – 82256

  VAT: DE264148280

   http://www.concentris.de


Complicit EU Projects



  Within the Horizon 2020 (2014-2020) framework, CONCENTRIS RESEARCH MANAGEMENT GMBH has received € 635,787.0 for its participation in a total of 2 project(s) with a total cost of € 15,452,278.

Start (YYYYMMDD) Project ID Project Name Themes End (YYYYMMDD) Role EC Contribution Total Cost IL Participation Total Participation CORDIS Link
2018-04-01 777084 DynaMORE data science  ·  public health  ·  posttraumatic stress disorder  ·  pathology  ·  mathematical model 2023-09-30 participant € 378,000.0 € 6,091,586 2 17 CORDIS ↪
2017-10-01 777364 EQIPD neurobiology  ·  data science  ·  alzheimer  ·  governance  ·  machine learning 2021-09-30 participant € 257,787.0 € 9,360,691 1 31 CORDIS ↪

  Within the Horizon Europe (2021-2027) framework, CONCENTRIS RESEARCH MANAGEMENT GMBH has received € 689,000.0 for its participation in a total of 1 project(s) with a total cost of € 9,845,090.

Start (YYYYMMDD) Project ID Project Name Themes End (YYYYMMDD) Role EC Contribution Total Cost IL Participation Total Participation CORDIS Link
2023-01-01 101096309 PANCAID DNA  ·  proteins  ·  RNA  ·  laboratory samples analysis  ·  pancreatic cancer 2027-12-31 participant € 689,000.0 € 9,845,090 2 20 CORDIS ↪

  Within the FP7 (2007-2013) framework, CONCENTRIS RESEARCH MANAGEMENT GMBH has received € 1,283,147.0 for its participation in a total of 3 project(s) with a total cost of € 70,993,581.

Start (YYYYMMDD) Project ID Project Name Themes End (YYYYMMDD) Role EC Contribution Total Cost IL Participation Total Participation CORDIS Link
2011-12-01 278367 EMTICS obsessive-compulsive disorder 2017-05-31 participant € 360,000.0 € 8,068,217 1 30 CORDIS ↪
2012-01-01 278948 TACTICS obsessive-compulsive disorder  ·  proteomics  ·  substance abuse  ·  paediatrics  ·  machine learning 2018-06-30 participant € 300,000.0 € 7,914,883 1 12 CORDIS ↪
2012-10-01 115439 STEMBANCC neurobiology  ·  drug discovery  ·  diabetes  ·  stem cells  ·  toxicology 2018-03-31 participant € 623,147.0 € 55,010,480 2 38 CORDIS ↪